Uroflowmetry in Children With Enuresis Nocturnal

• Sponsor: Hisar Intercontinental Hospital (Other)
• Overall Status: Completed
• CT.gov ID: NCT05190601
• Collaborator: (none)
• Enrollment: 180
• Location: 1
• Actual Duration (Months): 23.3
• Patients Per Site Per Month: 7.7

Study Details

Study Description

Brief Summary

Background: Enuresis nocturna is an important social and psychological problem in children. Uroflowmetry is an important test used to investigate lower urinary tract symptoms..

Objective:To evaluate the uroflowmetry (UFM) results of children with nocturnal enuresis (NE).

Method:

The uroflowmetry findings of healthy and visualized children without any urinary symptoms and who were prospectively admitted to the urology and pediatric surgery outpatient clinic with the complaint of Enuresis nocturna between January 2020 and July 2021 were compared. Information (anamnesis, physical examination, radiology results and laboratory tests) and uroflowmetry results of NE and healthy children included in the study were recorded.

Condition or Disease	Intervention/Treatment	Phase
Enuresis	Device: uroflowmetry

Detailed Description

SMale and Female,

Study Design

• Study Type: Observational [Patient Registry]
• Actual Enrollment: 180 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: How Valuable is Uroflowmetry in Children With Enuresis Nocturnal?
• Actual Study Start Date: Jan 1, 2020
• Actual Primary Completion Date: Jul 30, 2021
• Actual Study Completion Date: Dec 11, 2021

Arms and Interventions

Arm	Intervention/Treatment
Group 1 Enuresis nocturna with children	Device: uroflowmetry; Qmax(ml/s),Qav(ml/s),Volume (ml)

Outcome Measures

Primary Outcome Measures

1. uroflowmetry [2 years]

   ml/s

Eligibility Criteria

Criteria

• Ages Eligible for Study: 6 Years to 16 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

Primer monosymptomatic enuresis nocturna

Exclusion Criteria:

Urinary infectious Diabetes Spina bifida, Epispadias, Hipospadias VUR Extrophia Vesica Epilepsy Cerebral Palsy

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Hisar Intercontinental Hospital	Istanbul		Turkey	34768

Sponsors and Collaborators

• Hisar Intercontinental Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Basri Cakiroglu, Clinical Professor, Hisar Intercontinental Hospital
• ClinicalTrials.gov Identifier: NCT05190601
• Other Study ID Numbers: 14.102021/1600
• First Posted: Jan 13, 2022
• Last Update Posted: Jan 13, 2022
• Last Verified: Dec 1, 2021

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: Yes
• Keywords provided by Basri Cakiroglu, Clinical Professor, Hisar Intercontinental Hospital: enuresis nocturna; uroflowmetry; child
• Additional relevant MeSH terms: Enuresis; Urinary Incontinence; Nocturnal Enuresis

Study Results

No Results Posted as of Jan 13, 2022